Signatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest ModelOriginal paper
What was studied?
This study examined the mucosal microbiome of oral squamous cell carcinoma (OSCC) using 16S rRNA gene sequencing. Researchers compared the microbial profile and composition of cancerous lesions with matched paracancerous tissue from the same patients. A random forest (RF) machine learning model was applied to identify a microbial signature capable of distinguishing tumor tissue from adjacent normal-appearing tissue. Functional analyses were also performed to assess metabolic pathways associated with the tumor-associated microbiome.
Who was studied?
The study enrolled 24 patients diagnosed with oral squamous cell carcinoma. For each patient, paired samples were collected from the cancerous lesion and the matched paracancerous tissue, allowing within-patient comparison. No further demographic details are given in the abstract.
What were the most important findings?
Significant differences in microbial profile and composition were found between OSCC lesions and paracancerous tissue. LEfSe analysis identified 15 bacterial genera enriched in cancerous lesions, including Fusobacterium, Treponema, Streptococcus, Peptostreptococcus, Carnobacterium, Tannerella, Parvimonas, and Filifactor. The RF classifier identified a 12-bacteria signature that distinguished cancerous from paracancerous tissue with an AUC of 0.82, and the microbial network in cancerous lesions appeared simplified and fragmented. Functional analyses showed altered amino acid metabolism and increased capacity for glucose utilization in OSCC tissue.
What are the greatest implications of this study?
These findings suggest that a defined set of oral bacteria and their altered network structure are closely associated with the tumor microenvironment in OSCC. The RF-derived microbial signature, with an AUC of 0.82, points to the potential for microbiome-based classifiers to help distinguish cancerous from adjacent normal tissue. The shifts in amino acid and glucose metabolism suggest the tumor-associated microbiome may be functionally adapted to, or contribute to, the metabolic environment of the cancer, warranting further investigation into causal or diagnostic roles.